Cerebrospinal Fluid Management Market is segmented By Product Type (Ventriculoperitoneal (VP) Shunts, Ventriculoatrial (VA) Shunts, Lumboperitoneal (LP) Shunts, Ventricul ....
Market Size in USD
CAGR5.5%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 5.5% |
Market Concentration | High |
Major Players | Medtronic plc, Integra LifeSciences Corporation, B. Braun Melsungen AG, Sophysa, Spiegelberg GmbH & Co. KG |
The cerebrospinal fluid management market is estimated to be valued at USD 1.58 Bn in 2024 and is expected to reach USD 2.3 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031. Factors such as the increasing incidence of neurological disorders, rising geriatric population, and growing number of intensive care unit admissions are expected to fuel the demand for cerebrospinal fluid management procedures.